Differences in immunoglobulin subclasses between dye exclusion and 51Cr release complement-dependent...

Area of Science:

• Immunology
• Serology
• Clinical Diagnostics

Background:

• Complement-dependent lymphocytotoxicity assays, such as dye exclusion at room temperature (CDCE) and 51Cr release at 37°C (CDC51Cr), have shown paradoxical differences.
• These discrepancies suggest that the two methods may detect different immunological antibody-antigen interactions, particularly at 37°C.

Purpose of the Study:

• To compare the reactions of CDCE and CDC51Cr using identical target cells and sera.
• To investigate the influence of various serum treatments on the observed differences between the two assays.
• To elucidate the underlying mechanisms responsible for the divergent results in these clinically significant antibody detection systems.

Main Methods:

• Comparison of CDCE and CDC51Cr assay results using sera from specific patient groups (dialysis patients, aborting women, platelet recipients).
• Serum treatments included heat inactivation, heparin absorption, anti-light-chain augmentation, and addition of monoclonal anti-IgG subclass antibodies.
• Analysis of antibody-antigen interactions and immunoglobulin subclass involvement.

Main Results:

• Significant differences were observed between the CDCE and CDC51Cr tests when applied to the same target cells and sera.
• Evidence suggests the presence of both an inhibitor and an inhibitor of an inhibitor within the tested sera.
• The involvement of distinct immunoglobulin subclasses was implicated in the differential reactivity of the two assays.

Conclusions:

• The findings underscore significant mechanistic differences between CDCE and CDC51Cr assays.
• The study implies the presence of complex regulatory factors (inhibitors) influencing assay outcomes.
• Further investigation is crucial to understand the nature of these differences for improved clinical antibody detection.